Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age21-64
SponsorUniversity of New Mexico
About this trial
This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.
Eligibility criteria
Qualifiers
Men or women between the ages of 21 and 64 years of age
Lives in or near the participating communities of Blue Gap-Tachee Arizona or Red Water Pond Road Community New Mexico
Willing to provide blood and urine samples
Willing to attend study visits on scheduled dates
Disqualifiers
Women who are pregnant or nursing or women who plan to become pregnant during the course of the study.
Individuals who have self-reported diabetes, report that they are undergoing treatment for diabetes, or are currently taking medication for diabetes.
Known or suspected allergy to zinc.
Individuals previously diagnosed with syndromes of copper homeostasis (Menkes disease or Wilsons disease).
Trial design
Treatments tested in this trial
- Zinc Picolinate 15 Mg
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov